SCHEMBL20156211

SCHEMBL20156211

N#Cc1ccc(-c2ccc3c(c2)c2ccccc2n3-c2ccc(C#N)c(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c2)c(C#N)c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 1/20 0.36
ALDH1A1 P00352 3/20 0.36
LMNA P02545 3/20 0.36
MAPK1 P28482 2/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PTGER4 P35408 1/20 0.35
CYP1A2 P05177 3/20 0.34
CYP3A4 P08684 3/20 0.34
MEN1 O00255 2/20 0.34
CYP2C19 P33261 2/20 0.34
KMT2A Q03164 2/20 0.34
CLK4 Q9HAZ1 2/20 0.34
CYP2D6 P10635 2/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ABCG2 Q9UNQ0 5/20 0.34
STS P08842 1/20 0.34
ABCB1 P08183 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20156115 0.97 LMNA (0.38) NR3C1ALDH1A1LMNAMAPK1HPGD
SCHEMBL24125336 0.94 CYP1A2 (0.36) NR3C1ALDH1A1LMNAMAPK1HPGD
SCHEMBL20115023 0.94 ALDH1A1 (0.37) NR3C1ALDH1A1LMNAMAPK1HPGD
SCHEMBL20150429 0.92 ALDH1A1 (0.40) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL24125330 0.91 ALDH1A1 (0.36) NR3C1ALDH1A1LMNAMAPK1HPGD
SCHEMBL20155977 0.91 ALDH1A1 (0.38) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL20156192 0.91 NR3C1 (0.43) NR3C1ALDH1A1LMNAMAPK1HPGD
SCHEMBL22243127 0.91 PTGER4 (0.33) NR3C1ALDH1A1LMNAMAPK1HPGD
SCHEMBL27016256 0.91 CYP1A2 (0.39) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL27016260 0.90 ALDH1A1 (0.36) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 NR3C1 4383/4885ALDH1A1 387/4885LMNA 3586/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 NR3C1 4383/4885ALDH1A1 387/4885LMNA 3586/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.